Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China

医学 心房颤动 逻辑回归 人口学 人口 中国 流行病学 内科学 儿科 环境卫生 政治学 社会学 法学
作者
Xin Du,Lizhu Guo,Shijun Xia,Jing Du,Craig S. Anderson,Hisatomi Arima,Mark D. Huffman,Yiqiang Yuan,Yang Zheng,Shulin Wu,Xuefeng Guang,Xianhui Zhou,Hongbo Lin,Xiaoshu Cheng,Jianzeng Dong,Changsheng Ma
出处
期刊:Heart [BMJ]
卷期号:107 (7): 535-541 被引量:134
标识
DOI:10.1136/heartjnl-2020-317915
摘要

Objective To determine AF prevalence and gaps in atrial fibrillation (AF) awareness and management in China. Methods We conducted a community-based survey of 47 841 adults (age ≥45 years) in seven geographic regions of China between 2014 and 2016. Participants underwent a structured questionnaire, a standard 12-lead ECG, physical examination and blood sampling. AF prevalence, defined by either ECG detection or self-report, was estimated according to sampling weights, non-response and age and sex distribution of the population. We used multivariable logistic regression to estimate associations among sociodemographic, clinical and geographic factors with the AF prevalence, awareness and treatment. Results The weighted AF prevalence was 1.8% (95% CI 1.7% to 1.9%), but varied from 0.9% to 2.4% across geographical regions and equates to being present in an estimated 7.9 (95% CI 7.4 to 8.4) million people in China. Among men and women, the AF prevalence increased from 0.8% and 0.6% in the age group 45–54 years to 5.4% and 4.9% in the age group ≥75 years, respectively. Proportions of people who were aware of having AF decreased overall from 65.3% in 45–54 year-olds to 53.9% in ≥75 year-olds and varied between sex (men 58.5%, women 68.8%) and residency status (urban 78.3%, rural 35.3%). Only 6.0% of patients with high-risk AF received anticoagulation therapy. Conclusions AF prevalence is higher than previously reported in China, with low awareness and large treatment gaps. Large-scale efforts are urgently needed to reduce AF adverse consequences.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
尹文完成签到,获得积分10
1秒前
细腻的白容完成签到,获得积分10
1秒前
隐形曼青应助机智的阿丹采纳,获得10
2秒前
xiaodusb完成签到 ,获得积分10
2秒前
彭于晏应助嘻嘻采纳,获得10
3秒前
李健完成签到,获得积分10
3秒前
4秒前
5秒前
7秒前
大鱼完成签到,获得积分10
8秒前
8秒前
MJJJ发布了新的文献求助10
8秒前
量子星尘发布了新的文献求助10
9秒前
10秒前
10秒前
你好发布了新的文献求助10
10秒前
彬彬发布了新的文献求助20
11秒前
赘婿应助草木青采纳,获得10
12秒前
歇儿哒哒完成签到,获得积分10
14秒前
14秒前
Mency0101发布了新的文献求助10
14秒前
14秒前
14秒前
15秒前
今后应助俊宇采纳,获得10
15秒前
17秒前
chemj发布了新的文献求助10
18秒前
AN应助Peggy采纳,获得30
19秒前
圈圈发布了新的文献求助10
20秒前
四夕完成签到 ,获得积分10
21秒前
21秒前
阔达书雪发布了新的文献求助10
21秒前
海上森林的一只猫完成签到 ,获得积分10
21秒前
22秒前
pan发布了新的文献求助10
24秒前
26秒前
26秒前
chemj完成签到,获得积分20
26秒前
BANG完成签到,获得积分10
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Reproduction Third Edition 3000
Comprehensive Methanol Science Production, Applications, and Emerging Technologies 2000
化妆品原料学 1000
《药学类医疗服务价格项目立项指南(征求意见稿)》 1000
1st Edition Sports Rehabilitation and Training Multidisciplinary Perspectives By Richard Moss, Adam Gledhill 600
nephSAP® Nephrology Self-Assessment Program - Hypertension The American Society of Nephrology 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5633567
求助须知:如何正确求助?哪些是违规求助? 4729249
关于积分的说明 14986268
捐赠科研通 4791473
什么是DOI,文献DOI怎么找? 2558931
邀请新用户注册赠送积分活动 1519330
关于科研通互助平台的介绍 1479617